JP2008508363A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508363A5 JP2008508363A5 JP2007524945A JP2007524945A JP2008508363A5 JP 2008508363 A5 JP2008508363 A5 JP 2008508363A5 JP 2007524945 A JP2007524945 A JP 2007524945A JP 2007524945 A JP2007524945 A JP 2007524945A JP 2008508363 A5 JP2008508363 A5 JP 2008508363A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition
- seq
- cysteine residues
- terminal cysteine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- 235000001014 amino acid Nutrition 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000027455 binding Effects 0.000 claims 3
- 102000003923 Protein Kinase C Human genes 0.000 claims 2
- 210000004899 c-terminal region Anatomy 0.000 claims 2
- 230000004656 cell transport Effects 0.000 claims 2
- 230000036755 cellular response Effects 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 101000914947 Bungarus multicinctus Long neurotoxin homolog TA-bm16 Proteins 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000010410 reperfusion Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59845804P | 2004-08-02 | 2004-08-02 | |
| US59840104P | 2004-08-02 | 2004-08-02 | |
| PCT/US2005/027567 WO2006017578A2 (en) | 2004-08-02 | 2005-08-02 | Peptide sequence for modulation of delta protein kinase c |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508363A JP2008508363A (ja) | 2008-03-21 |
| JP2008508363A5 true JP2008508363A5 (enExample) | 2008-09-11 |
Family
ID=35610069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007524945A Pending JP2008508363A (ja) | 2004-08-02 | 2005-08-02 | δプロテインキナーゼＣの調節のためのペプチド配列 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090155236A1 (enExample) |
| EP (1) | EP1784483A2 (enExample) |
| JP (1) | JP2008508363A (enExample) |
| AU (1) | AU2005271477A1 (enExample) |
| CA (1) | CA2575123A1 (enExample) |
| WO (1) | WO2006017578A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7635680B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaceuticals, Inc. | Attenuation of reperfusion injury |
| WO2008005487A2 (en) * | 2006-06-30 | 2008-01-10 | The Board Of Trustees Of The Leland | Peptide sequences for modulation of protein kinase c |
| US7851587B2 (en) * | 2006-10-02 | 2010-12-14 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides derived from the C2 domain of epsilon PKC |
| CA2989778C (en) | 2007-01-19 | 2020-06-30 | Kai Pharmaceuticals, Inc. | Method of modifying peptide compositions |
| EP2234631B1 (en) | 2007-12-18 | 2012-09-12 | Athera Biotechnologies AB | Compounds and methods for the treatment of vascular disease |
| WO2011041385A2 (en) | 2009-09-29 | 2011-04-07 | Joslin Diabetes Center, Inc. | Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis |
| US9078913B2 (en) | 2009-11-06 | 2015-07-14 | University Of Rochester | Use of human Biliverdin reductase and fragments thereof protein kinase C-δ and ERK related conditions |
| JP2024046503A (ja) * | 2022-09-22 | 2024-04-03 | シスメックス株式会社 | 細胞外小胞に含まれるアルカリフォスファターゼの活性を測定する方法、キャリブレータ及び結合体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002057413A2 (en) * | 2001-01-18 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for activation and inhibition of delta pkc |
-
2005
- 2005-08-02 US US11/659,305 patent/US20090155236A1/en not_active Abandoned
- 2005-08-02 WO PCT/US2005/027567 patent/WO2006017578A2/en not_active Ceased
- 2005-08-02 CA CA002575123A patent/CA2575123A1/en not_active Abandoned
- 2005-08-02 EP EP05783056A patent/EP1784483A2/en not_active Withdrawn
- 2005-08-02 AU AU2005271477A patent/AU2005271477A1/en not_active Abandoned
- 2005-08-02 JP JP2007524945A patent/JP2008508363A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005505579A5 (enExample) | ||
| EP2573109A3 (en) | Peptide vaccines comprising Seq Id 101, 80 or 100 for cancers expressing tumor-associated antigens | |
| JP2004521108A5 (enExample) | ||
| NO20071369L (no) | Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv | |
| IN2014CN02050A (enExample) | ||
| WO2002008251A3 (en) | Peptides as ns3-serine protease inhibitors of hepatitis c virus | |
| JP2005516885A5 (enExample) | ||
| JP2007529204A5 (enExample) | ||
| EP2476697A3 (en) | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | |
| EP2508601A3 (en) | Tem8 peptides and vaccines comprising the same | |
| WO2009025116A1 (ja) | Cdh3ペプチド及びこれを含む薬剤 | |
| WO2007076162A3 (en) | Antimicrobial cathelicidin peptides | |
| WO2019148194A3 (en) | Peptidyl inhibitors of calcineurin-nfat interaction | |
| JP2008508363A5 (enExample) | ||
| JP2007535910A5 (enExample) | ||
| JP2005502663A5 (enExample) | ||
| WO2008113536A8 (en) | Neurotrophic peptides | |
| WO2005118627A3 (en) | Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| WO2009066462A1 (ja) | 細胞傷害性ｔ細胞の誘導方法、細胞傷害性ｔ細胞の誘導剤、およびそれを用いた医薬組成物およびワクチン | |
| WO2008047370A3 (en) | Compositions and methods for inducing angiogenesis | |
| WO2007029262A3 (en) | Compositions and methods using same for the detection of viruses | |
| JP2009510134A5 (enExample) | ||
| WO2009020189A1 (ja) | 血圧降下剤 | |
| WO2009105780A3 (en) | Mntf peptide compositions and methods of use |